The difference of lipid profiles between psoriasis with arthritis and psoriasis without arthritis and sex-specific downregulation of methotrexate on the apolipoprotein B/apolipoprotein A-1 ratio.

Wang, Bing; Deng, Hui; Hu, Yao; Han, Ling; Huang, Qiong; Fang, Xu; Yang, Ke; Wu, Siyuan; Zheng, Zhizhong; Yawalkar, Nikhil; Zhang, Zhenghua; Yan, Kexiang (2022). The difference of lipid profiles between psoriasis with arthritis and psoriasis without arthritis and sex-specific downregulation of methotrexate on the apolipoprotein B/apolipoprotein A-1 ratio. Arthritis research & therapy, 24(1), p. 17. BioMed Central 10.1186/s13075-021-02715-4

[img]
Preview
Text
s13075-021-02715-4.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (887kB) | Preview

BACKGROUND

Methotrexate (MTX) has a protective effect against cardiovascular diseases (CVD), but the mechanism is unclear.

OBJECTIVE

To investigate the effect of MTX on lipid profiles and the difference between psoriasis without arthritis (PsO) and psoriatic arthritis (PsA).

METHODS

In this prospective study, we recruited 288 psoriatic patients (136 PsA and 152 PsO) who completed 12 weeks of MTX treatment. Total cholesterol (TC), triglycerides (TG), lipoprotein A [LP(a)], high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein (LDL), apolipoprotein A1 (ApoA1), and ApoB were measured.

RESULTS

Compared with sex- and age-matched healthy controls, psoriatic patients had significantly (p < 0.0001) higher levels of proatherogenic lipids and lower levels of anti-atherogenic lipids. PsA patients had a higher ApoB/ApoA1 ratio than PsO patients (p < 0.05). Stepwise regression analysis found a positive correlation between the inflammatory marker hCRP and the Psoriasis Area Severity Index (PASI), ApoB/ApoA1 ratio, BMI, and smoking. ApoB was positively associated with concomitant arthritis, diabetes, and hypertension. MTX decreased the levels of pro-atherogenic and anti-atherogenic lipids. However, a significant reduction of the ApoB/ApoA1 ratio by MTX was only observed in male patients.

CONCLUSION

PsA patients had a significantly higher percentage of concomitant disease than PsO. The decrease of MTX on CVD might be related with sex.

TRIAL REGISTRATION

ChiCTR2000036192.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Yawalkar, Nikhil

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1478-6354

Publisher:

BioMed Central

Language:

English

Submitter:

Andrea Studer-Gauch

Date Deposited:

15 Feb 2022 14:10

Last Modified:

05 Dec 2022 16:06

Publisher DOI:

10.1186/s13075-021-02715-4

PubMed ID:

34996506

Uncontrolled Keywords:

Apolipoproteins Lipid profiles Methotrexate Psoriasis Psoriatic arthritis

BORIS DOI:

10.48350/164919

URI:

https://boris.unibe.ch/id/eprint/164919

Actions (login required)

Edit item Edit item
Provide Feedback